Monica Guevara

Summary

Country: Spain

Publications

  1. ncbi request reprint Hepatorenal syndrome
    Monica Guevara
    Liver Unit, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, University of Barcelona, C Villarroel 173, 08032 Barcelona, Spain
    Int J Biochem Cell Biol 37:22-6. 2005
  2. doi request reprint Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy
    Monica Guevara
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain
    J Hepatol 55:564-73. 2011
  3. doi request reprint Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis
    Monica Guevara
    Liver Unit, Hospital Clinic, University of Barcelona, Villarroel 170, Barcelona, Spain
    Am J Gastroenterol 104:1382-9. 2009
  4. doi request reprint Hepatorenal syndrome
    Monica Guevara
    Hospital Clinic Barcelona, Liver Unit, IDIBAPS, CIBERHED, Barcelona, Spain
    Expert Opin Pharmacother 12:1405-17. 2011
  5. ncbi request reprint Hepatorenal syndrome
    Monica Guevara
    Liver Unit, Hospital Clinic, Institut d Investigacions Biomèdiques August Pi Sunyer, University of Barcelona School of Medicine, Barcelona, Catalunya, Spain
    Dig Dis 23:47-55. 2005
  6. doi request reprint Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration
    Monica Guevara
    Liver Unit Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
    Liver Int 30:1137-42. 2010
  7. ncbi request reprint Effects of contrast media on renal function in patients with cirrhosis: a prospective study
    Monica Guevara
    Liver Unit, Hospital Clinic, Barcelona, Spain
    Hepatology 40:646-51. 2004
  8. ncbi request reprint [Treatment of ascites and the hepatorenal syndrome]
    Monica Guevara
    Hospital Clinic de Barcelona, IDIBAPS, Universidad de Barcelona, Villarroel 170 08036 Barcelona, Espana
    Acta Gastroenterol Latinoam 34:27-35. 2004
  9. ncbi request reprint [Transjugular intrahepatic portosystemic shunt and refractory ascites]
    M Guevara
    Servicio de Hepatologia, Institut de Malalties Digestives, Hospital Clinic, Barcelona, Espana
    Gastroenterol Hepatol 27:285-91. 2004
  10. ncbi request reprint [Treatment of hepatorenal syndrome]
    M Guevara
    Unidad de Hepatología Hospital Clínic Barcelona España
    Gastroenterol Hepatol 26:270-4. 2003

Collaborators

Detail Information

Publications42

  1. ncbi request reprint Hepatorenal syndrome
    Monica Guevara
    Liver Unit, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, University of Barcelona, C Villarroel 173, 08032 Barcelona, Spain
    Int J Biochem Cell Biol 37:22-6. 2005
    ..They also appear to improve survival and may serve as a bridge to liver transplantation, which is the treatment of choice in these patients...
  2. doi request reprint Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy
    Monica Guevara
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain
    J Hepatol 55:564-73. 2011
    ..We applied advanced magnetic resonance imaging and Voxed based Morphometry analysis to assess brain tissue density in patients with cirrhosis...
  3. doi request reprint Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis
    Monica Guevara
    Liver Unit, Hospital Clinic, University of Barcelona, Villarroel 170, Barcelona, Spain
    Am J Gastroenterol 104:1382-9. 2009
    ..The aim of this study was to investigate whether hyponatremia is a risk factor of overt hepatic encephalopathy (HE) in cirrhosis...
  4. doi request reprint Hepatorenal syndrome
    Monica Guevara
    Hospital Clinic Barcelona, Liver Unit, IDIBAPS, CIBERHED, Barcelona, Spain
    Expert Opin Pharmacother 12:1405-17. 2011
    ..Renal failure in cirrhosis is a common complication that is associated with poor survival. A rapid diagnosis of the cause of renal failure is mandatory because it is associated with prognosis...
  5. ncbi request reprint Hepatorenal syndrome
    Monica Guevara
    Liver Unit, Hospital Clinic, Institut d Investigacions Biomèdiques August Pi Sunyer, University of Barcelona School of Medicine, Barcelona, Catalunya, Spain
    Dig Dis 23:47-55. 2005
    ....
  6. doi request reprint Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration
    Monica Guevara
    Liver Unit Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
    Liver Int 30:1137-42. 2010
    ..In conclusion, in patients with refractory ascites, the occurrence of HE is related to the impairment of liver and renal function and presence of hyponatraemia...
  7. ncbi request reprint Effects of contrast media on renal function in patients with cirrhosis: a prospective study
    Monica Guevara
    Liver Unit, Hospital Clinic, Barcelona, Spain
    Hepatology 40:646-51. 2004
    ..Cirrhosis does not appear to be a risk factor for the development of contrast media-induced nephrotoxicity...
  8. ncbi request reprint [Treatment of ascites and the hepatorenal syndrome]
    Monica Guevara
    Hospital Clinic de Barcelona, IDIBAPS, Universidad de Barcelona, Villarroel 170 08036 Barcelona, Espana
    Acta Gastroenterol Latinoam 34:27-35. 2004
  9. ncbi request reprint [Transjugular intrahepatic portosystemic shunt and refractory ascites]
    M Guevara
    Servicio de Hepatologia, Institut de Malalties Digestives, Hospital Clinic, Barcelona, Espana
    Gastroenterol Hepatol 27:285-91. 2004
  10. ncbi request reprint [Treatment of hepatorenal syndrome]
    M Guevara
    Unidad de Hepatología Hospital Clínic Barcelona España
    Gastroenterol Hepatol 26:270-4. 2003
  11. ncbi request reprint Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score
    Carlos Terra
    Liver Unit, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
    Gastroenterology 129:1944-53. 2005
    ..Background &..
  12. ncbi request reprint Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival
    Rogelio Barreto
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain Institut d Investigacions Biomèdiques August Pi Sunyer IDIBAPS, Barcelona, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHED, Barcelona, Spain Instituto Reina Sofia de Investigación Nefrológica, Barcelona, Spain
    Hepatology 59:1505-13. 2014
    ..These results may help advance the management of patients with type-1 HRS associated with infections...
  13. ncbi request reprint Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study
    Rolando Ortega
    Liver Unit, Institut de Malalties Digestives, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomédiques August Pi Sunyer IDIBAPS, Catalunya, Spain
    Hepatology 36:941-8. 2002
    ..In conclusion, terlipressin therapy reverses HRS in a high proportion of patients. Recurrence rate after treatment withdrawal is uncommon. Albumin appears to improve markedly the beneficial effects of terlipressin...
  14. doi request reprint Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study
    Monica Guevara
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
    J Hepatol 57:759-65. 2012
    ..Whether albumin has similar beneficial effects in patients with infections other than SBP is unknown...
  15. doi request reprint Prognostic importance of the cause of renal failure in patients with cirrhosis
    Marta Martín-Llahí
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Gastroenterology 140:488-496.e4. 2011
    ..The prognostic value of the different causes of renal failure in cirrhosis is not well established. This study investigated the predictive value of the cause of renal failure in cirrhosis...
  16. doi request reprint A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis
    Claudia Fagundes
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
    J Hepatol 59:474-81. 2013
    ..The Acute Kidney Injury Network (AKIN) criteria are widely used in nephrology, but information on cirrhosis is limited. We aimed at evaluating the AKIN criteria and their relationship with the cause of kidney impairment and survival...
  17. ncbi request reprint Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis
    Dara de Las Heras
    Liver Unit, Department of Pulmonary Medicine, and Hormonal Laboratory, Hospital Clinic, University of Barcelona, Catalunya, Spain
    Hepatology 38:452-9. 2003
    ..Increased CO production may participate in the disturbance of circulatory function that occurs during severe bacterial infections in cirrhosis...
  18. ncbi request reprint MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation
    Carlo Alessandria
    Liver Unit, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
    Hepatology 41:1282-9. 2005
    ..These data can be useful in the management of patients with HRS, particularly for patients who are candidates for liver transplantation...
  19. ncbi request reprint Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation
    Maria Carlota Londoño
    Liver Unit, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
    Gastroenterology 130:1135-43. 2006
    ..We aimed to assess the effects of hyponatremia at the time of transplantation on posttransplantation outcome in patients with cirrhosis...
  20. ncbi request reprint Hyponatremia in cirrhosis: clinical features and management
    Marta Martín-Llahí
    Liver Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Spain
    Gastroenterol Clin Biol 30:1144-51. 2006
    ..In addition, the possible beneficial effects of these drugs in the prevention of hepatic encephalopathy would be worth studying...
  21. pmc MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation
    Maria Carlota Londoño
    Liver Unit, Hospital Clinic, Universitat de Barcelona, Institut de Investigacions Biomèdiques August Pi Sunyer, CIBER de Enfermedades Hepáticas y Digestivas and Centro de Investigaciones Biomédicas Esther Koplowitz, Barcelona, Spain
    Gut 56:1283-90. 2007
    ....
  22. doi request reprint Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study
    Gustavo Pereira
    University of Barcelona, Barcelona, Spain
    J Hepatol 56:1040-6. 2012
    ..This study aimed at assessing the characteristics, occurrence of renal failure, and outcome of cirrhotic patients with skin and soft tissue infection...
  23. doi request reprint LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction
    André Nazar
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
    J Hepatol 58:51-7. 2013
    ..The current study aimed at assessing the potential role of cardiac abnormalities in the pathogenesis of circulatory and renal dysfunction in cirrhosis...
  24. doi request reprint Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis
    Claudia Fagundes
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
    J Hepatol 57:267-73. 2012
    ..We aimed at assessing the usefulness of neutrophil gelatinase-associated lipocalin (NGAL), a biomarker of tubular damage, in the differential diagnosis of impairment of kidney function in cirrhosis...
  25. doi request reprint [Hyponatremia in liver cirrhosis: pathogenesis and treatment]
    Monica Guevara
    Servei d Hepatologia, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d Investigacions Biomèdiques August Pi Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain
    Endocrinol Nutr 57:15-21. 2010
    ..Since hypervolemic hyponatremia is by far the most frequent form of this disorder, the present chapter will concentrate specifically on hypervolemic hyponatremia in cirrhosis...
  26. doi request reprint Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study
    Marta Martín-Llahí
    Liver Unit, Hospital Clinic, University of Barcelona School of Medicine, Institut d Investigacions Biomédiques August Pi Sunyer IDIBAPS, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Barcelona, Spain
    Gastroenterology 134:1352-9. 2008
    ..Hepatorenal syndrome is common in patients with advanced cirrhosis and constitutes a major problem in liver transplantation. There is no effective medical treatment for hepatorenal syndrome...
  27. ncbi request reprint Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome
    Christina Esteva-Font
    Molecular Biology Laboratory, Fundacio Puigvert, Barcelona, Spain
    Hepatology 44:1555-63. 2006
    ..Finally, aquaporin-1 does not appear to play a role in the progressive dysregulation of extracellular fluid volume in cirrhosis...
  28. ncbi request reprint Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis
    Tea Restuccia
    Liver Unit, Hospital Clinic, Barcelona, Spain
    Hepatology 39:1613-22. 2004
    ..These findings may be relevant to the pathogenesis of encephalopathy in hyponatremic patients...
  29. doi request reprint Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema
    Elsa Solá
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
    J Hepatol 57:1199-206. 2012
    ..We aimed at assessing the relationship between serum sodium concentration and other clinical and analytical parameters on HRQL in cirrhosis with ascites...
  30. ncbi request reprint Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study
    Tea Restuccia
    Liver Unit, Institute for Digestive Diseases, Hospital Clinic, University of Barcelona, Villarroel 170, Barcelona 08036, Catalunya, Spain
    J Hepatol 40:140-6. 2004
    ..Pretransplant renal function is the major determinant of survival after liver transplantation (LTx). Patients with hepatorenal syndrome (HRS) have a poor outcome after LTx compared with patients transplanted without HRS...
  31. doi request reprint Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome
    André Nazar
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
    Hepatology 51:219-26. 2010
    ..001). Corresponding values in patients with an increase in mean arterial pressure >or=5 mm Hg or <5 mm Hg at day 3 were 73% and 36%, respectively (P = 0.037)...
  32. doi request reprint Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension
    Elsa Solá
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
    Hepatology 52:1783-90. 2010
    ....
  33. doi request reprint Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis
    Andres Cardenas
    GI Unit, Institut de Malalties Digestives i Metaboliques, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain
    J Hepatol 56:571-8. 2012
    ..Specific data on the safety and efficacy of tolvaptan in patients with cirrhosis and hyponatremia has not been exclusively evaluated...
  34. ncbi request reprint Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections
    Rogelio Barreto
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain Institut d Investigacions Biomèdiques August Pi Sunyer IDIBAPS, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHED, Spain Instituto Reina Sofía de Investigación Nefrológica IRSIN, Spain
    J Hepatol 61:35-42. 2014
    ..We aimed at assessing the value of urinary neutrophil gelatinase-associated lipocalin (uNGAL), a biomarker overexpressed in kidney tubules during kidney injury, in predicting clinical outcomes in cirrhosis with infections...
  35. doi request reprint Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis
    Jose Altamirano
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Clin Gastroenterol Hepatol 10:65-71.e3. 2012
    ..We studied effects of acute kidney injury (AKI) on survival of patients with AH...
  36. ncbi request reprint Hepatorenal syndrome
    Pere Gines
    Liver Unit, Hospital Cli nic, Institut d Investigacions Biomèdiques August Pi Sunyer, University of Barcelona School of Medicine, Barcelona, Catalunya, Spain
    Lancet 362:1819-27. 2003
    ..Although these findings need to be confirmed, these two strategies represent innovative approaches to lower the frequency of HRS in clinical practice...
  37. ncbi request reprint Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis
    Ezequiel Rodríguez
    Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain Institut d Investigacions Biomèdiques August Pi Sunyer IDIBAPS, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHED, Spain Instituto Reina Sofía de Investigación Nefrológica IRSIN, Spain
    J Hepatol 60:955-61. 2014
    ..Study aim was to investigate the effects of early treatment with terlipressin and albumin on circulatory and kidney function in patients with type-1 HRS and sepsis and assess factors predictive of response to therapy...
  38. ncbi request reprint Hepatorenal syndrome in cirrhosis: pathogenesis and treatment
    Vicente Arroyo
    Liver Unit, Institute of Digestive Disease, Hospital Clinic, University of Barcelona, Villaroel 170, 08036 Barcelona, Spain
    Gastroenterology 122:1658-76. 2002
  39. doi request reprint Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management
    Pere Gines
    Liver Unit, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomèdiques August Pi Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas IDIBAPS, Barcelona, Catalunya, Spain
    Hepatology 48:1002-10. 2008
    ..Treatment with vaptans represents a novel approach to improving serum sodium concentration in cirrhosis...
  40. doi request reprint [Biomarkers of acute kidney injury: a « trending topic » in cirrhosis]
    Rogelio Barreto
    Unidad de Hepatologia, Hospital Clinic, Universidad de Barcelona, Barcelona, Espana
    Gastroenterol Hepatol 36:407-21. 2013
    ..The present article discusses the most promising candidate biomarkers with potential application in cirrhosis, such as NGAL, KIM-1, cystatin-C, IL-18, L-FABP, N-acetyl glucosaminidase and netrin-1, are discussed below...
  41. ncbi request reprint Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study
    Macarena Simón-Talero
    Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d Hebron, Institut de Recerca VHIR, Universitat Autonoma de Barcelona, Barcelona, Spain
    J Hepatol 59:1184-92. 2013
    ..The aim of this study is to assess the efficacy of albumin in a multicenter, prospective, double-blind, controlled trial (ClinicalTrials.gov number, NCT00886925)...
  42. ncbi request reprint Recent advances in hepatorenal syndrome
    Vicente Arroyo
    Liver Unit, Hospital Clinic, Institut d Investigacions Biomèdiques August Pi Sunyer, University of Barcelona School of Medicine, Barcelona, Catalunya, Spain
    Trop Gastroenterol 26:13-20. 2005
    ..Nevertheless, liver transplantation should still be done in suitable patients even after improvement of renal function because the outcome of HRS is poor...